← All organizations

CNAO National Center of Oncological Hadrontherapy

Academic/Hospital

Also known as: CNAO National Center of Oncological Hadrontherapy

Highest phase reached

Phase 2

First clinical trial

Feb 8, 2018

Last known activity

Mar 31, 2022

Timeline

No events for the selected filters.

Drugs by trial phase (3 distinct, 2 trials)

Phase 2 (3 own, 0 via acquisition)

Indications

Recent trials (4)

  • NCT05229614Lead sponsorPhase 2Mar 31, 2022
  • NCT03822936Lead sponsorPhase 2Feb 8, 2018
  • NCT03822936Overall official - principal investigatorPhase 2Feb 8, 2018
  • NCT03822936Reponsible party - principal investigatorPhase 2Feb 8, 2018

Details

Last known activity
Mar 31, 2022